LinusBio

LinusBio is a biotech company in North Brunswick, United States, founded in 2020. It has raised $24.0M across 2 rounds, most recently a $16.0M Series A in January 2023.

The next revolution in precision medicine

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$24.0M
Last Round
$16.0M Series AJan 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

LinusBio is a pioneering precision medicine platform company developing exposomic biomarkers from single strands of hair to enable earlier disease diagnoses, enhanced patient monitoring, and accelerated drug development. The company's proprietary temporal exposomics sequencing platform uses robotics, laser systems, and mass spectrometry to analyze the molecular growth rings in hair, revealing thousands of biological features across multiple time points. LinusBio's AI-powered pipeline transforms these exposomic readouts into actionable clinical insights. The company's lead product, ClearStrand-ASD, is the first commercially available non-invasive diagnostic aid for Autism Spectrum Disorder, capable of detecting a biomarker associated with autism in children as young as one month of age using a single hair strand.

Summary

It lists 11–50 employees. It has raised $24.0M in total across 2 rounds, most recently a $16.0M Series A round in Jan 2023.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJan 2023
$16.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

LinusBio on Indexed.vc
<a href="https://indexed.vc/companies/linusbio"><img src="https://indexed.vc/api/badge/company/linusbio" alt="LinusBio on Indexed.vc" width="260" height="76" /></a>